At 48 weeks, the first patient dosed experienced hearing improvement to near-normal levels at key speech-relevant frequencies based on auditory brainstem responses (ABRs). Results of formal ...
This included hearing thresholds that were within normal limits (0.25-2.0 kHz) in most speech-relevant frequencies and corroborated with positive auditory brainstem responses (ABRs). Particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback